Author
Senior reporter
Covid-19: Big pharma to the rescue
As the world watches and waits for a vaccine, we ask what IR is like under the pandemic spotlight
‘The scrutiny is extraordinarily high,’ says Nick Mazing, director of research at Sentieo, talking about the media and market focus on pharmaceuticals and biotech firms involved in the fight against Covid-19. ‘And it’s not just scrutiny. It is interference.’
As
Content Preview
to continue reading
Subscribe
- IR Essentials - print editions
- Unlimited Articles online
- Newsletter
- Award Winning IR reports
- Strategy guides
- White papers
from$995*
Case studies
‘Claims of positive alpha in popular industry publications are not valid because the analysis underlying these claims is flawed,’ state the authors...Read more
The best and brightest of the Canadian IR community gathered online yesterday for the IR Magazine Awards – Canada 2021. Canadian Pacific Railway was...Read more
The Investor Perception Study – Canada 2021 looks at the current leading companies and individuals for IR in Canada as voted for by the...Read more
Best practice IR had to be reimagined last year as the Covid-19 pandemic shut down travel and in-person events. Companies were forced to experiment...Read more
